Developmental and Neurotoxicity of Acrylamide to Zebrafish

Int J Mol Sci. 2021 Mar 29;22(7):3518. doi: 10.3390/ijms22073518.

Abstract

Acrylamide is a commonly used industrial chemical that is known to be neurotoxic to mammals. However, its developmental toxicity is rarely assessed in mammalian models because of the cost and complexity involved. We used zebrafish to assess the neurotoxicity, developmental and behavioral toxicity of acrylamide. At 6 h post fertilization, zebrafish embryos were exposed to four concentrations of acrylamide (10, 30, 100, or 300 mg/L) in a medium for 114 h. Acrylamide caused developmental toxicity characterized by yolk retention, scoliosis, swim bladder deficiency, and curvature of the body. Acrylamide also impaired locomotor activity, which was measured as swimming speed and distance traveled. In addition, treatment with 100 mg/L acrylamide shortened the width of the brain and spinal cord, indicating neuronal toxicity. In summary, acrylamide induces developmental toxicity and neurotoxicity in zebrafish. This can be used to study acrylamide neurotoxicity in a rapid and cost-efficient manner.

Keywords: acrylamide; developmental toxicity; disease models; neurodevelopmental disorders; neurotoxicity; zebrafish.

MeSH terms

  • Acrylamide / pharmacology
  • Acrylamide / toxicity*
  • Air Sacs / pathology
  • Animals
  • Animals, Genetically Modified
  • Disease Models, Animal
  • Embryo, Nonmammalian / drug effects*
  • Embryo, Nonmammalian / physiopathology
  • Embryonic Development / drug effects
  • Neurotoxicity Syndromes / etiology
  • Neurotoxicity Syndromes / physiopathology*
  • Scoliosis / etiology
  • Swimming
  • Zebrafish / growth & development*
  • Zebrafish / physiology

Substances

  • Acrylamide